Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinomaDavid A. Braun, Toni K. Choueiri, Yue Hou et al.|Nature Medicine|2020Cited by 1k
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinomaKevin Bi, Eliezer M. Van Allen, Meng Xiao He et al.|Cancer Cell|2021Cited by 624
Progressive immune dysfunction with advancing disease stage in renal cell carcinomaDavid A. Braun, Catherine J. Wu, Kelly Street et al.|Cancer Cell|2021Cited by 515
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinomaZiad Bakouny, Srinivas R. Viswanathan, David A. Braun et al.|Nature Communications|2021Cited by 167
Impact of Histological Variants on Clinical Outcomes of Patients with Upper Urinary Tract Urothelial CarcinomaMichael Rink, Shahrokh F. Shariat, Nathalie Rioux‐Leclercq et al.|The Journal of Urology|2012Cited by 142